Asia-Pacific Laxative Market, By Type (Osmotic Laxatives, Stimulant Laxatives, Bulk Laxatives and Lubricant and Emollient laxatives), Flavors (With Flavor and Without Flavor), Source (Natural, Synthetic and Others), Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation and Others), Mode of Purchase (Prescription and Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories and Others), Route of Administration (Oral and Rectal), Population Type (Children and Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, Grocery/Health and Beauty Stores and Others), Distribution channel (Direct Sales, Wholesalers and Others) – Industry Trends and Forecast to 2030.
Asia-Pacific Laxative Market Analysis and Size
Asia-Pacific laxative market has experienced significant growth due to the high burden of an increase in aging population are the major drivers which propelled the demand of the market. High level safety associated with laxative products and rising emphasis on production of laxatives from natural, synthetic and biodegradable materials are the major drivers which propelled the demand of the market in the forecast period.
Data Bridge Market Research analyses that the Asia-Pacific laxative market which was USD 6,914.12 million in 2022, is expected to reach USD 12,034.12 million by 2030, and is expected to undergo a CAGR of 7.0% during the forecast period of 2023 to 2030. “Osmotic Laxatives” dominates the type segment of the Asia-Pacific laxative market due to changing lifestyle and dietary. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Laxative Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Osmotic Laxatives, Stimulant Laxatives, Bulk Laxatives and Lubricant and Emollient laxatives), Flavors (With Flavor and Without Flavor), Source (Natural, Synthetic and Others), Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation and Others), Mode of Purchase (Prescription and Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories and Others), Route of Administration (Oral and Rectal), Population Type (Children and Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, Grocery/Health and Beauty Stores and Others), Distribution channel (Direct Sales, Wholesalers and Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy's Laboratories Ltd. (India), Lupin (India), Fresenius Kabi AG (Germany), Aurobindo Pharma (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), Eli Lilly and Company (U.S.) and among other
|
|
Market Opportunities
|
|
Market Definition
Laxative are the agents which either increase/stimulate bowel movement or loosen stools. They help in accelerate intestinal transit, which speed up the movement of digestive tract to stimulate bowel movement. Itis used for treating constipation, a condition characterized by difficult, infrequent and sometime painful bowel movement. The laxatives are available as Over the Counter (OTC). The four main types of laxative are osmotic laxative, a stimulant laxative, bulk laxative, lubricant, and emollient laxative.
Asia-Pacific Laxative Market Dynamics
Drivers
- Changing Lifestyle and Dietary Habits
The Asia-Pacific region has witnessed a significant shift in lifestyle and dietary habits over the past few decades. As urbanization has accelerated and sedentary lifestyles have become more prevalent, there has been a noticeable increase in gastrointestinal issues, particularly constipation. This shift can be attributed to reduced physical activity, inadequate fiber intake, and a growing preference for processed and convenience foods. These dietary and lifestyle changes have led to a rising incidence of constipation, driving the demand for laxative products in the region.
- Increased Healthcare Awareness
The Asia-Pacific region has seen a notable increase in healthcare awareness and accessibility. This rise in awareness has led to greater recognition and diagnosis of gastrointestinal disorders, including constipation. Patients are now more likely to seek medical advice and opt for pharmaceutical solutions, contributing to the expanding market for laxatives.
- Consumer Preference for OTC Laxatives
Over-the-counter (OTC) laxatives have gained popularity in the Asia-Pacific region due to their convenience and accessibility. Consumers appreciate the ease of purchasing these products without the need for a prescription. Moreover, OTC laxatives are often considered a first-line treatment for mild and occasional constipation. This consumer preference for readily available OTC laxatives has further fueled the growth of the laxative market.
Opportunities
- Rising Health and Wellness Trends
The increasing focus on health and wellness among consumers presents a notable opportunity for laxative manufacturers. Beyond merely providing relief from constipation, manufacturers can position their products as contributors to overall digestive health. This approach aligns with the growing trend of consumers seeking products that promote holistic well-being, creating a potential avenue for market growth.
- Product Innovation in Laxative Formulation
Continuous innovation in laxative formulations offers significant opportunities for market expansion. Manufacturers can invest in research and development to develop gentler and more natural laxatives with fewer side effects. Innovations that enhance tolerability and reduce discomfort associated with laxative use can resonate with consumers seeking effective yet gentle solutions for constipation relief.
Restraints/Challenges
- Stringent Regulatory Oversight
Regulatory bodies in the Asia-Pacific region impose strict regulations on the sale and distribution of pharmaceutical products, including laxatives. These regulations are in place to ensure consumer safety and product efficacy. Manufacturers must adhere to stringent standards and undergo rigorous testing and approvals processes. Compliance with regulatory requirements can lead to increased operational costs and limitations on marketing activities, posing a significant restraint in the market.
- Cultural and Dietary Variations across the Asia-Pacific
Cultural and dietary variations across the Asia-Pacific region require a nuanced and culturally sensitive approach to marketing laxatives. Manufacturers must consider local preferences, traditional remedies, and healthcare practices when promoting their products. Failure to navigate these cultural factors effectively can impact market acceptance and success.
This Asia-Pacific laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In October 2021, Abbott had launched the Duphalac laxative in India. Duphalac Bears in strawberry flavor is a laxative cum food supplement and has met with the FSSAI regulations. It delivers the advantages of a trusted prebiotic and motivates the growth of good bacteria in the digestive system. The product launch would pave an important step in the children’s health improvement. It will result in increased net sales and more product range
Asia-Pacific Laxative Market Analysis and Size
Asia-Pacific laxative market has experienced significant growth due to the high burden of an increase in aging population are the major drivers which propelled the demand of the market. High level safety associated with laxative products and rising emphasis on production of laxatives from natural, synthetic and biodegradable materials are the major drivers which propelled the demand of the market in the forecast period.
Data Bridge Market Research analyses that the Asia-Pacific laxative market which was USD 6,914.12 million in 2022, is expected to reach USD 12,034.12 million by 2030, and is expected to undergo a CAGR of 7.0% during the forecast period of 2023 to 2030. “Osmotic Laxatives” dominates the type segment of the Asia-Pacific laxative market due to changing lifestyle and dietary. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Laxative Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Osmotic Laxatives, Stimulant Laxatives, Bulk Laxatives and Lubricant and Emollient laxatives), Flavors (With Flavor and Without Flavor), Source (Natural, Synthetic and Others), Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation and Others), Mode of Purchase (Prescription and Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories and Others), Route of Administration (Oral and Rectal), Population Type (Children and Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, Grocery/Health and Beauty Stores and Others), Distribution channel (Direct Sales, Wholesalers and Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy's Laboratories Ltd. (India), Lupin (India), Fresenius Kabi AG (Germany), Aurobindo Pharma (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), Eli Lilly and Company (U.S.) and among other
|
|
Market Opportunities
|
|
Market Definition
Laxative are the agents which either increase/stimulate bowel movement or loosen stools. They help in accelerate intestinal transit, which speed up the movement of digestive tract to stimulate bowel movement. Itis used for treating constipation, a condition characterized by difficult, infrequent and sometime painful bowel movement. The laxatives are available as Over the Counter (OTC). The four main types of laxative are osmotic laxative, a stimulant laxative, bulk laxative, lubricant, and emollient laxative.
Asia-Pacific Laxative Market Dynamics
Drivers
- Changing Lifestyle and Dietary Habits
The Asia-Pacific region has witnessed a significant shift in lifestyle and dietary habits over the past few decades. As urbanization has accelerated and sedentary lifestyles have become more prevalent, there has been a noticeable increase in gastrointestinal issues, particularly constipation. This shift can be attributed to reduced physical activity, inadequate fiber intake, and a growing preference for processed and convenience foods. These dietary and lifestyle changes have led to a rising incidence of constipation, driving the demand for laxative products in the region.
- Increased Healthcare Awareness
The Asia-Pacific region has seen a notable increase in healthcare awareness and accessibility. This rise in awareness has led to greater recognition and diagnosis of gastrointestinal disorders, including constipation. Patients are now more likely to seek medical advice and opt for pharmaceutical solutions, contributing to the expanding market for laxatives.
- Consumer Preference for OTC Laxatives
Over-the-counter (OTC) laxatives have gained popularity in the Asia-Pacific region due to their convenience and accessibility. Consumers appreciate the ease of purchasing these products without the need for a prescription. Moreover, OTC laxatives are often considered a first-line treatment for mild and occasional constipation. This consumer preference for readily available OTC laxatives has further fueled the growth of the laxative market.
Opportunities
- Rising Health and Wellness Trends
The increasing focus on health and wellness among consumers presents a notable opportunity for laxative manufacturers. Beyond merely providing relief from constipation, manufacturers can position their products as contributors to overall digestive health. This approach aligns with the growing trend of consumers seeking products that promote holistic well-being, creating a potential avenue for market growth.
- Product Innovation in Laxative Formulation
Continuous innovation in laxative formulations offers significant opportunities for market expansion. Manufacturers can invest in research and development to develop gentler and more natural laxatives with fewer side effects. Innovations that enhance tolerability and reduce discomfort associated with laxative use can resonate with consumers seeking effective yet gentle solutions for constipation relief.
Restraints/Challenges
- Stringent Regulatory Oversight
Regulatory bodies in the Asia-Pacific region impose strict regulations on the sale and distribution of pharmaceutical products, including laxatives. These regulations are in place to ensure consumer safety and product efficacy. Manufacturers must adhere to stringent standards and undergo rigorous testing and approvals processes. Compliance with regulatory requirements can lead to increased operational costs and limitations on marketing activities, posing a significant restraint in the market.
- Cultural and Dietary Variations across the Asia-Pacific
Cultural and dietary variations across the Asia-Pacific region require a nuanced and culturally sensitive approach to marketing laxatives. Manufacturers must consider local preferences, traditional remedies, and healthcare practices when promoting their products. Failure to navigate these cultural factors effectively can impact market acceptance and success.
This Asia-Pacific laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In October 2021, Abbott had launched the Duphalac laxative in India. Duphalac Bears in strawberry flavor is a laxative cum food supplement and has met with the FSSAI regulations. It delivers the advantages of a trusted prebiotic and motivates the growth of good bacteria in the digestive system. The product launch would pave an important step in the children’s health improvement. It will result in increased net sales and more product range
Asia-Pacific Laxative Market Scope
The Asia-Pacific laxative market is segmented on the basis of type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Osmotic Laxatives
- Stimulant Laxatives
- Bulk Laxatives and Lubricant
- Emollient laxatives
Flavors
- With Flavors
- Without Flavors
Source
- Natural
- Synthetic
- Others
Indication
- Chronic Constipation
- Irritable Bowel Syndrome with Constipation
- Opioid-Induced constipation
- Acute constipation
- Others
Mode of Purchase
- Prescription
- Over-the-Counter
Dosage Form
- Tablets
- Capsules
- Powder
- Liquid and Gels
- Suppositories
- Others
Route of Administration
- Oral
- Rectal
Population Type
- Children
- Adults
Sales Channel
- Hospitals
- Elderly Care Centers
- Home Healthcare
- Pharmacy Stores
- Grocery/Health and Beauty Stores
- Others
Distribution Channel
- Direct Sales
- Wholesalers
- Others
Asia-Pacific Laxative Market Regional Analysis/Insights
The Asia-Pacific laxative market is analysed and market size insights and trends are provided by type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.
The countries covered in the Asia-Pacific Laxative market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC).
China is leading the growth of the Asia-Pacific region and pharmaceutical/bulk drug intermediates segment is dominating in this country because China is the highest active pharmaceutical ingredient producer globally. India is the fastest growing country due to rising government initiatives for the production of APIs.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Asia-Pacific Laxative market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific Laxative market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific Laxative market. The data is available for historic period 2015 to 2020.
Competitive Landscape and Asia-Pacific Laxative Market Share Analysis
The Asia-Pacific Laxative market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to Asia-Pacific laxative market.
Some of the major players operating in the Asia-Pacific laxative market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Novartis AG (Switzerland)
- Merck & Co., Inc. (U.S.)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Dr. Reddy's Laboratories Ltd. (India)
- Lupin (India)
- Fresenius Kabi AG (Germany)
- Aurobindo Pharma (India)
- Cipla Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Amneal Pharmaceuticals LLC. (U.S.)
- Apotex Inc. (Canada)
- Eli Lilly and Company (U.S.)
The Asia-Pacific laxative market is segmented on the basis of type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Osmotic Laxatives
- Stimulant Laxatives
- Bulk Laxatives and Lubricant
- Emollient laxatives
Flavors
- With Flavors
- Without Flavors
Source
- Natural
- Synthetic
- Others
Indication
- Chronic Constipation
- Irritable Bowel Syndrome with Constipation
- Opioid-Induced constipation
- Acute constipation
- Others
Mode of Purchase
- Prescription
- Over-the-Counter
Dosage Form
- Tablets
- Capsules
- Powder
- Liquid and Gels
- Suppositories
- Others
Route of Administration
- Oral
- Rectal
Population Type
- Children
- Adults
Sales Channel
- Hospitals
- Elderly Care Centers
- Home Healthcare
- Pharmacy Stores
- Grocery/Health and Beauty Stores
- Others
Distribution Channel
- Direct Sales
- Wholesalers
- Others
Asia-Pacific Laxative Market Regional Analysis/Insights
The Asia-Pacific laxative market is analysed and market size insights and trends are provided by type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.
The countries covered in the Asia-Pacific Laxative market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC).
China is leading the growth of the Asia-Pacific region and pharmaceutical/bulk drug intermediates segment is dominating in this country because China is the highest active pharmaceutical ingredient producer globally. India is the fastest growing country due to rising government initiatives for the production of APIs.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Asia-Pacific Laxative market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific Laxative market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific Laxative market. The data is available for historic period 2015 to 2020.
Competitive Landscape and Asia-Pacific Laxative Market Share Analysis
The Asia-Pacific Laxative market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to Asia-Pacific laxative market.
Some of the major players operating in the Asia-Pacific laxative market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Novartis AG (Switzerland)
- Merck & Co., Inc. (U.S.)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Dr. Reddy's Laboratories Ltd. (India)
- Lupin (India)
- Fresenius Kabi AG (Germany)
- Aurobindo Pharma (India)
- Cipla Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Amneal Pharmaceuticals LLC. (U.S.)
- Apotex Inc. (Canada)
- Eli Lilly and Company (U.S.)
SKU-